More on JAZZ
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Product sales, net | 371.62M |
| Royalties | |
| Contract revenues | |
| Total revenues | 374.18M |
| Cost of product sales (excluding amortization of acquired developed technology) | |
| Selling, general and administrative | 124.37M |
| Research and development | 47.8M |
| Intangible asset amortization | 26.45M |
| Total operating expenses | 237.93M |
| Income from operations | 136.25M |
| Interest income and other, net | |
| Interest expense (including $255 and $570 for the three and six months ended June 30, 2010, respectively, pertaining to a related party) | |
| Loss on extinguishment of debt (including $701 pertaining to a related party) | |
| Net income (loss) | 87.15M |
| Basic | 1.44 |
| Diluted | 1.41 |
| Basic | 60.44M |
| Diluted | 61.64M |
Entities mentioned with JAZZ
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
